Immunomedics Competitors, Revenue and Alternatives

Claim your profile

Overview

Location:
Total Funding:N/A
Industry:Biotech
Founded:1982
Lead Investor(s):Goldman, Sachs & Co.
Press
Claim your profile

Industry Ranking

State Ranking

Estimated Revenue & Financials

  • Immunomedics's estimated annual revenue is currently $34.6M per year.
  • Immunomedics received $125.0M in venture funding in May 2017.
  • Immunomedics's estimated revenue per employee is $87,065

Employee Data

  • Immunomedics has 397 Employees.
  • Immunomedics grew their employee count by 27% last year.
  • Immunomedics currently has 63 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Hydromer
$10.4M67N/AN/A
Cellectar Biosc...
N/A20N/AN/A
Soligenix
N/A28N/AN/A
Gibraltar Labor...
$10.7M69N/AN/A
Apprentice.io
$4.7M30N/AN/A
AES CHEMUNEX
$4M26N/AN/A
GENEWIZ
$91.1M5883%N/A
Amicus Therapeu...
$91.2M555-12%N/A
Celsion Corpora...
N/A40N/AN/A
Hitachi Chemica...
$47.6M30713%N/A
Missing a competitor? Contribute!?
Submit

Immunomedics is a clinical-stage biopharmaceutical company developing monoclonal antibody-based products for the targeted treatment of cancer and other serious diseases. Immunomedics corporate objective is to become a fully-integrated biopharmaceutical company and a leader in the field of antibody-drug conjugates.

keywords:Biotechnology,Cleantech,Healthcare,Medical Diagnostics,Pharmaceuticals,Wind Power

397

Number of Employees

$34.6M

Revenue (est)

63

Current Jobs

27%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

B2B

Type

Executive Contacts

NameTitleEmail
Joseph AmalrajTechnical Director, ITEmail Available
Rahul PatelDirector, Validation & ComplianceEmail Available
Brendan DelaneyChief Commercial OfficerEmail Available
Joseph HenleyDirector, Bioreactor ProductionEmail Available
Paul QuinnNorth Central Region Business DirectorEmail Available
Jeff ReyesDirector, R&D Business ITEmail Available
Karrie Spath HilsingerClinical Program Study Director
Ashok MarinVice President, Deputy General Counsel, Chief Compliance Officer & Chief Privacy OfficerEmail Available
Katrina GekasOncology Account ManagerEmail Available
Velumani PillaiHead of Data, Digital Services and InnovationEmail Available

Immunomedics News

12-Sep-19 - Immunomedics to Host Investor Event and Webcast on ...

12, 2019 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical ...

12-Sep-19 - Immunomedics (IMMU) Looks Good: Stock Adds 6.1% in ...

Immunomedics, Inc. IMMU was a big mover last session, as the company saw its shares rise more than 6% on the day. The move came on solid ...

4-Sep-19 - Immunomedics Announces Oral Presentation of Sacituzumab ...

Immunomedics Announces Oral Presentation of Sacituzumab Govitecan in Metastatic Urothelial Cancer at ESMO 2019 Annual Congress ...

Immunomedics Funding

DateAmountRoundLead InvestorsReference
2004-01-15$10.0MnotesArticle
2005-04-28$36.7MUndisclosedMultipleArticle
2014-05-05$30.2MUndisclosedArticle
2015-02-09$96.4MUndisclosedGoldman, Sachs & Co.Article
2017-05-08$125.0MUndisclosedArticle

Immunomedics Executive Hires

DateNameTitleReference
2001-09-12Gerald GormanCFOArticle
2002-03-26Terence RuggCMO & SVPArticle
2002-05-03Ivan HorakEVP Research & DevelopmentArticle
2013-09-04Peter PfreundschuhCFO/VP FinanceArticle
2015-01-07Francois E. WilhelmChief Medical OfficerArticle
2016-06-22Michael R. GaroneVP Finance/CFOArticle
2017-05-08Michael GaroneInterim CEOArticle
2019-02-27Scott Canuteexecutive directorArticle